Citation

85 FR 58063

Canonical document for this Federal Register citation.

Eisai, Inc.; Withdrawal of Approval of Two New Drug Application for BELVIQ (lorcaserin hydrochloride) and BELVIQ XR (lorcaserin hydrocholoride) Thursday, September 17, 2020 85 FR 58063